Abstract:Phyllanthi Fructus (PF) is a tropical fruit with the potential to effectively reduce postprandial blood glucose, making it highly promising for the development of functional foods. However, the lack of quantitative evaluation methods and comprehensive understanding of active compounds has hindered the development and application of functional foods and dietary supplements derived from PF. In this study, a biological evaluation method of the hypoglycemic activity of PF based on α-glucosidase inhibition was established for the first time. With acarbose as the positive drug and ultrasonic water extract of PF as the test material, the hypoglycemic potency of PF could be accurately evaluated using the "parallel line method of mass reaction". The correlation coefficient (r) between the potency evaluation results and the AUC of postprandial blood glucose concentration in rats was as high as 0.866, confirming a strong correlation between our evaluation results and in vivo effects. The potency of 20 batches of PF samples ranged from 2.66 to 8.39 U·mg-1 with a maximum difference of 3.15-fold. UF-LC-MS was used to identify 36 components of PF capable of binding to α-glucosidase. Molecular docking results showed that the binding energy was between -3.5 and -14.3 kJ/mol. The hypoglycemic activity of 17 available control products was tested and 8 inhibitors were found, including hyperoside, gallic acid and corilagin. Further analysis suggested that flavonoids and polyphenols with a phenolic hydroxyl structure could inhibit α-glucosidase. This study provides valuable information and methodological support for developing PF hypoglycemic functional foods and discovering new active ingredients.

[A New Flavanol Glycoside from Phymatopteris Hastata with Effect on Glucose Metabolism].

A New Flavan-3-ol Lactone and Other Constituents from Euonymus Alatus with Inhibitory Activities on Α-Glucosidase and Differentiation of 3T3-L1 Cells.

Carboxymethyl Flavonoids and a Monoterpene Glucoside from Selaginella Moellendorffii.

Flavonoids from Tetrastigma obtectum enhancing glucose consumption in insulin-resistance HepG2 cells via activating AMPK.

Synthesis and Anti-Hyperglycemic Activity of Hesperidin Derivatives

Hypoglycemic flavonoids from Selaginella tamariscina (P.Beauv.) Spring

Synthesis & Alpha-Glucosidase Inhibitory & Glucose Consumption-Promoting Activities O Flavonoid-Coumarin Hybrids

Total Synthesis of 8-(6″-umbelliferyl)-apigenin and Its Analogs As Anti-Diabetic Reagents.

Structural Characterization and Antidiabetic Potential of a Novel Heteropolysaccharide from Grifola Frondosa Via IRS1/PI3K-JNK Signaling Pathways.

Homoisoflavonoids from the Fibrous Roots of Polygonatum Odoratum with Glucose Uptake-Stimulatory Activity in 3T3-L1 Adipocytes.

A New Flavanone from Seeds of Psoralea corylifolia with alpha-Glucosidase Inhibitory Activity

In Vitro and in Silico Analysis of PTP1B Inhibitors from Cleistocalyx operculatus Leaves and Their Effect on Glucose Uptake

Two New Flavanols from Glycosmis Pentaphylla.

Selaginellin and biflavonoids as protein tyrosine phosphatase 1B inhibitors from Selaginella tamariscina and their glucose uptake stimulatory effects

Flavonoid derivatives synthesis and anti-diabetic activities

Impact of Preparative Isolation of C-Glycosylflavones Derived from Dianthus Superbus on in Vitro Glucose Metabolism.

New Metabolite with Inhibitory Activity Against Α-Glucosidase and Α-Amylase from Endophytic Chaetomium Globosum

Two new monoterpenes from Tithonia diversifolia and their anti-hyperglycemic activity

Investigation of the hypoglycemic bioactive components of Phyllanthi Fructus through biological assessment combined with ultrafiltration affinity mass spectrometry

Multi-target anti-diabetic styrylpyrones from Phellinus igniarius: Inhibition of α-glucosidase, protein glycation, and oxidative stress

A New Flavonol Derivative from Fagopyrum Dibotrys